Tuesday, 25 January, 2022
HomeIndiaGovernanceNew medicine that can cure flu in just one day gets US...

New medicine that can cure flu in just one day gets US drug regulator’s nod

Text Size:

Compared to Tamiflu that requires two doses daily for 5 days, now a single dose of Xofluza can cure the illness. New drug to reach Indian market in 2-3 years.

New Delhi: Bouts of influenza or the flu that causes headaches, runny nose, cough and muscle pain may now be cured in just one day — and with just one pill.

The US drug regulator — Food and Drug Administration (US FDA) — has approved a new drug, Xofluza, which works differently from other flu drugs. Compared to Tamiflu, which requires two doses daily for a five-day course, a single dose of Xofluza can cure the illness in just one day.

Xofluza has been found to reduce symptoms and duration of the flu — a contagious respiratory illness caused by influenza viruses — if the patient is treated within 48 hours of becoming sick.

The earlier studies conducted by its Japanese parent firm has suggested that Xofluza (baloxavir marboxil) stopped an infected person from passing the virus to others within 24 hours against the other treatments that took 72 hours.

On 24 October, the USFDA approved Xofluza, made by Japanese pharmaceutical company Shionogi for the treatment of acute uncomplicated influenza. The drug has been approved for patients who are of or above 12 years of age.

“This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years,” FDA commissioner Scott Gottlieb said in the press statement.

Also read: PM Modi is writing letters to 100 million families to educate them about Modicare

Why taking the entire dose is important

The flu infection, otherwise, is self-limiting with severe illness lasting for three to four days. Most people recover within a week after consuming non-prescription medicines such as Tamilflu, D’Cold Total and Cheston Cold.

Sometimes, not finishing the entire course of the medication could help certain viruses to become drug resistant, which may create a life-threatening flu infection or aggravate existing illnesses.

Seasonal flu kills up to 6.5 lakh people every year, according to the World Health Organization, with most deaths occurring from pneumonia, heart or brain inflammation and circulatory shock from organs not getting enough blood or oxygen.

In the new drug, there are no chances of missing any dose and hence, it can prove more effective with lesser side effects.

Also read: Early diagnosis, regular exercise and healthy diet could protect you against osteoporosis

New drug likely to arrive in India in 2-3 years

After the USFDA approval, Indian manufacturers will file applications with the Central Drugs Standard Control Organisation to take permissions for the manufacture of the formulation of drug ‘baloxavir marboxil’.

“CDSCO will then order the clinical trial of drugs at four different geographies on at least 100 patients. The launch of drug will take at least two to three years in India,” said Ashok Kumar Madan, executive director of Indian Drug Manufacturer Association.

Doctors in India, however, refused to comment on the approval of the drug as they are awaiting the nod from CDSCO after the clinical trials on local patients.

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism


  1. I do not think the author of this article is a medical professional nor is she familiar with the medical terms used. No research has claimed that either Tamiflu or the new drug Baloxavir are cures of the illness per se. Both drugs are most useful to prevent spread of infection rather than to cure the disease within the patient himself. They reduce the severity or duration of the illness which is what the research mentions. Baloxavir does not cure in a single day. Its dosage is a single dose, that is all. There is a huge difference in medical terms between those two sentences. Also, your author forgot to mention that either Oseltamivir or Baloxavir are effective only if taken within 48 hours of onset of illness. In India, getting the infected sample to a recognised lab and getting the report to confirm the disease takes 2 weeks.

Comments are closed.

Most Popular